The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials DOI Creative Commons

Mi-Mi Zhang,

Yan Zou, Sumin Li

и другие.

Translational Psychiatry, Год журнала: 2020, Номер 10(1)

Опубликована: Июнь 17, 2020

Abstract Omega-3 fatty acids (FA), as a nutrient, has been proven effective in major depressive disorder (MDD), however, the results of monotherapy perinatal depression (PND) remain unclear. To examine efficacy and safety omega-3 (FA) for compared with placebo. PubMed, Embase, PsycINFO, MEDLINE, Cochrane Library, CINAHL were searched from inception up to November 2019. The reference lists relevant review articles included studies also reviewed. Randomized placebo-controlled trials examining FA women symptoms included. Pooled standard mean differences (SMD) calculated random-effects models adopted all analyses. Subgroups analyses meta-regression performed quantify characteristics subjects influencing response. In addition, was conducted identify source heterogeneity. study protocol registered at PROSPERO, CRD42020159542. Eight eligible randomized involving 638 participants. There significant effect on depression. higher ratio EPA/DHA (≥1.5) had both mild-to-moderate pregnant postpartum low incidence side effects. Among reporting adverse effects, there no difference gastrointestinal neurologic events between placebo groups. evidence publication bias. Our findings suggested that significantly improved regardless or well-tolerated. Furthermore, response linked EPA proportion formula mild- to-moderate

Язык: Английский

Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy DOI
Ping‐Tao Tseng,

Bing‐Syuan Zeng,

Mein‐Woei Suen

и другие.

Brain Behavior and Immunity, Год журнала: 2023, Номер 111, С. 352 - 364

Опубликована: Май 6, 2023

Язык: Английский

Процитировано

28

Dietary docosahexaenoic acid (DHA) downregulates liver DHA synthesis by inhibiting eicosapentaenoic acid elongation DOI Creative Commons

Adam H. Metherel,

Rodrigo Valenzuela, Brinley J. Klievik

и другие.

Journal of Lipid Research, Год журнала: 2024, Номер 65(6), С. 100548 - 100548

Опубликована: Апрель 21, 2024

DHA is abundant in brain where it regulates cell survival, neurogenesis and neuroinflammation. can be obtained from the diet or synthesized alpha-linolenic acid (ALA; 18:3n-3) via a series of desaturation elongation reactions occurring liver. Tracer studies suggest that dietary downregulate its own synthesis, but mechanism remains undetermined primary objective this paper. First, we show by tracing 13C content (δ13C) compound-specific isotope analysis (CSIA), following low DHA, receives ALA. We then increases mouse liver serum EPA, which dependant on Furthermore, CSIA demonstrate source increased EPA slowed metabolism, not retroconversion as previously assumed. feeding alone with ALA lowered very long-chain (ELOVL2, elongation) enzyme activity despite no change protein content. To further evaluate role ELOVL2, liver-specific Elovl2 knockout was generated showing presence absence functional ELOVL2 yields similar results. An competition assay for suggests both uncompetitive non-competitive inhibition depending levels. translate our findings, supplementation men women levels manner dependent SNP (rs953413) gene. In conclusion, identify novel feedback pathway downregulates synthesis inhibiting elongation.

Язык: Английский

Процитировано

14

Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials DOI
Wolfgang Marx, Andrew Scholey, Joseph Firth

и другие.

Neuroscience & Biobehavioral Reviews, Год журнала: 2020, Номер 118, С. 472 - 484

Опубликована: Авг. 26, 2020

Язык: Английский

Процитировано

64

Gut-brain axis: A matter of concern in neuropsychiatric disorders…! DOI
Muhammad Naveed,

Qi-Gang Zhou,

Xu Chu

и другие.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2020, Номер 104, С. 110051 - 110051

Опубликована: Авг. 4, 2020

Язык: Английский

Процитировано

61

The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials DOI Creative Commons

Mi-Mi Zhang,

Yan Zou, Sumin Li

и другие.

Translational Psychiatry, Год журнала: 2020, Номер 10(1)

Опубликована: Июнь 17, 2020

Abstract Omega-3 fatty acids (FA), as a nutrient, has been proven effective in major depressive disorder (MDD), however, the results of monotherapy perinatal depression (PND) remain unclear. To examine efficacy and safety omega-3 (FA) for compared with placebo. PubMed, Embase, PsycINFO, MEDLINE, Cochrane Library, CINAHL were searched from inception up to November 2019. The reference lists relevant review articles included studies also reviewed. Randomized placebo-controlled trials examining FA women symptoms included. Pooled standard mean differences (SMD) calculated random-effects models adopted all analyses. Subgroups analyses meta-regression performed quantify characteristics subjects influencing response. In addition, was conducted identify source heterogeneity. study protocol registered at PROSPERO, CRD42020159542. Eight eligible randomized involving 638 participants. There significant effect on depression. higher ratio EPA/DHA (≥1.5) had both mild-to-moderate pregnant postpartum low incidence side effects. Among reporting adverse effects, there no difference gastrointestinal neurologic events between placebo groups. evidence publication bias. Our findings suggested that significantly improved regardless or well-tolerated. Furthermore, response linked EPA proportion formula mild- to-moderate

Язык: Английский

Процитировано

57